US Drug Recall Register
Class II · Moderate risk Terminated Initiated Oct 28, 2020 (6 years ago)

Mesalamine Delayed-Release Tablets, USP 1.2 gram, 120 tablets per bottle, Rx Only…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Failed Dissolution Specifications: Out-of-specification dissolution results were obtained during stability testing.

What was recalled

Mesalamine Delayed-Release Tablets, USP 1.2 gram, 120 tablets per bottle, Rx Only, Manufactured by: Actavis Laboratories, FL, Inc., Fort Lauderdale, FL 33314, Distributed by: Actavis Pharma Inc., Parsippany, NJ 07054, NDC 0591-2245-22.

Recalling firm
Teva Pharmaceuticals USA
NDC code
0591-2245-22
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0069-2021

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Mesalamine recalls

See all